Cite
HARVARD Citation
Srimuninnimit, V. et al. (n.d.). Efficacy and safety of sorafenib in combination with gemcitabine in patients with advanced hepatocellular carcinoma: A multicenter, open‐label, single‐arm phase II study. Asia-Pacific journal of clinical oncology. 10 (3), pp. 255-260. [Online].